Skip to main navigation Skip to search Skip to main content

Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease - Thailand multicenter study

  • Kritvikrom Durongpisitkul
  • , Duangmanee Laoprasitiporn
  • , Thanarat Layangool
  • , Rekwan Sittiwankul
  • , Mannat Panamonta
  • , Pirapat Mokrapong
  • Siriraj Hospital
  • Queen Sirikit National Institute of Child Health
  • Faculty of Medicine, Chiang Mai University
  • Faculty of Medicine, Khon Kaen University
  • Rajavithi Hospital

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Background: Congenital heart disease patients who have pulmonary hypertension (PH) require an evaluation for pulmonary vascular reactivity before surgical repair. In the present study the acute pulmonary vasodilating effects of 100% oxygen (O2), beraprost sodium (BPS) and 40 ppm inhaled nitric oxide (iNO) during cardiac catheterization were compared. Methods and Results: There were 90 patients who underwent cardiac catheterization for evaluation of PH (mean age, 16.5±16 years). The baseline mean pulmonary artery (mPA) pressure was 69.6±14.8 mmHg and the pulmonary arteriolar resistance (Rpa) was 13.8±8.3 Wood unit m2. Change in pulmonary vascular reactivity was defined as a decrease in mPA or Rpa >20% from baseline. The response to 100%O2, iNO and BPS during cardiac catheterization was 84%, 72.7% and 64%, respectively. Pair comparisons among each hemodynamic parameter showed no difference between the acute vasodilating effect of BPS and iNO. In some patients BPS showed a stronger effect than iNO in lowering Rpa. Conclusions: BPS has a similar pulmonary vasodilating effect to iNO and can be used as an acute pulmonary vasodilating agent during cardiac catheterization with potential benefits over iNO.

Original languageEnglish
Pages (from-to)61-64
Number of pages4
JournalCirculation Journal
Volume69
Issue number1
DOIs
Publication statusPublished - Jan 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Beraprost sodium
  • Congenital heart disease
  • Pulmonary hypertension

Fingerprint

Dive into the research topics of 'Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease - Thailand multicenter study'. Together they form a unique fingerprint.

Cite this